title: New prostate cancer drugs: extending and improving life.
authors.affiliation: University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA.
authors.forename: Neeraj
authors.initials: N
authors.lastname: Agarwal
authors.affiliation: University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
authors.forename: Tanya
authors.initials: T
authors.lastname: Dorff
authors.affiliation: University of Southern California Keck School of Medicine and Norris Comprehensive Cancer Center, Los Angeles, CA, USA. Electronic address: agoldkor@med.usc.edu.
authors.forename: Amir
authors.initials: A
authors.lastname: Goldkorn
mesh_terms: D001549:Benzamides; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D006801:Humans; D008297:Male; D009570:Nitriles; D010669:Phenylthiohydantoin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000401:mortality*; D011788:Quality of Life
chemical_list: D001549:Benzamides; D009570:Nitriles; D010669:Phenylthiohydantoin; C540278:enzalutamide